- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
BALAXI PHARMACEUTICALS LIMITED — Important, 05-08-2026: Updates
05-08-2026 | 02:01 pm
05-08-2026 | 02:01 pm
Balaxi Pharmaceuticals commenced commercial production at its new pharma plant, launching 2 products. The company secured approvals for 29 additional products, expanding its portfolio to 31, and is progressing towards WHO-GMP certification. Consolidated Q1 revenue was 80.68 Cr, with a net profit of 1.30 Cr.
No comments yet. Be the first to comment!